In May 2022, the US Food and Drug Administration (FDA) published the final guidance for industry, Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors.
The guidance document provides a set of principles and recommendations for ensuring that critical elements of a product’s container label and carton labeling are designed to promote safe dispensing , administration, and use of the product.
Join Med Safety Board for a free webinar in which our medication safety experts will review the significant changes that were incorporated into the final FDA guidance, including new recommendations on displaying certain critical information, differentiating look-alike products, and other key labeling considerations. Real-world examples will also be shared to demonstrate the importance of applying this guidance when designing container and carton labeling.
Don’t miss this opportunity to better understand FDA’s current thinking on safe medication container labeling in order to minimize the potential for errors and risk with your organization’s products!